- Contractors
- Glaxosmithkline, LLC
Glaxosmithkline, LLC
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Glaxosmithkline has 61 federal contracts of $100,000 or more active since October 2023, with $271M obligated, from 8 agencies or more. 11 are still running, 9 ending within 18 months.
- Contracts
- 61 since FY2024$270,664,385 obligated, contracts of $100,000 or more
- Running now
- 11 contracts7 ended in the last 12 months
- Biggest customer
- Office of Assistant Secretary for Preparedness and Response$238M on 36 contracts
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- FRHTPHMZMX47Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2020 | $618,076 |
| FY2021 | $516,000 |
| FY2022 | $26,152,276 |
| FY2023 | $17,518,872 |
| FY2024 | $75,622,809 |
| FY2025 | $55,557,936 |
| FY2026 | $1,044,470 |
| FY2027 | $686,968 |
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount, $M | Share |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response36 contracts | 237.6 | |
| Centers for Disease Control and Prevention3 contracts | 19.8 | |
| Indian Health Service3 contracts | 6.4 | |
| Department of State4 contracts | 2.6 | |
| Defense Logistics Agency1 contract | 1.6 | |
| Office of the Assistant Secretary for Administration5 contracts | 1.2 | |
| Department of Veterans Affairs5 contracts | 0.6 | |
| Office of Procurement Operations1 contract | 0.5 |
What they sell
| Industry | Amount, $M | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 18 contracts | 112.1 | |
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 · 17 contracts | 72.8 | |
| Pharmaceutical Preparation ManufacturingNAICS 325412 · 22 contracts | 65.7 | |
| Medicinal and Botanical ManufacturingNAICS 325411 · 2 contracts | 18.4 | |
| Refrigerated Warehousing and StorageNAICS 493120 · 1 contract | 1.4 | |
| Medical, Dental, and Hospital Equipment and Supplies Merchant WholesalersNAICS 423450 · 1 contract | 0.2 |
Where the work is
| Place of work | Amount, $M | Share |
|---|---|---|
| North Carolina52 contracts | 232.4 | |
| Georgia3 contracts | 26.4 | |
| Pennsylvania1 contract | 4.7 | |
| Oklahoma1 contract | 2.8 | |
| Virginia2 contracts | 1.2 | |
| California1 contract | 0.1 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.
Get new notices like Glaxosmithkline's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy